Procter & Gamble Fights an Uphill Battle in Q4

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Procter & Gamble Fights an Uphill Battle in Q4

© Public Domaine / Wikimedia Commons

Procter & Gamble Co. (NYSE: PG | PG Price Prediction) reported its fiscal fourth-quarter financial results before the markets opened on Thursday. The company said that it had $1.16 in earnings per share (EPS) and $17.7 billion in revenue, while consensus estimates were $1.01 in EPS and revenue of $16.97 billion. The same period of last year reportedly had EPS of $1.10 on $17.09 billion in revenue.

[in-text-ad]

During the latest quarter, net sales increased 4% year over year. This was affected by unfavorable foreign exchange rates and, obviously, the COVID-19 pandemic. However, excluding forex, net sales increased 6%, primarily driven by an increase in organic shipment volume.

Organic shipment volume increased 3% as strong consumer demand for household cleaning, personal health and cleansing products in North America and certain European markets rose due to the pandemic. This was partially offset by volume decreases in other regions due primarily to temporary disruption of consumer access to retail markets related to the pandemic.

[nativounit]

In terms of its segments, the company reported as follows:

  • Beauty net sales were flat year over year at $3.18 billion.
  • Grooming net sales decreased by 5% to $1.51 billion.
  • Health Care net sales decreased by 1% to $2.02 billion.
  • Fabric & Home Care increased by 11% to $6.29 billion.
  • Baby, Feminine & Family Care increased 3% to $4.62 billion.

Looking ahead to the 2021 fiscal full year, the company said that it expects to see core EPS growth in the range of 3% to 7% and all-in sales growth of 1% to 3%. Consensus estimates are calling for $4.95 in EPS and $70.14 billion in revenue for the full year.

Procter & Gamble stock hit a new 52-week high of $130.92 early Thursday. That is above the consensus price target of $130.69, and the 52-week low is $94.34.

[recirclink id=726473][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618